KKR to acquire medtech maker Integer in $5.7 billion deal

KKR announced an agreement to take Integer private for approximately $5.7 billion, offering $127 per share in cash to Integer stockholders.

Integer, based in Plano, Texas, saw its shares rise about 2.7% to $124.50 after the news. The transaction includes the assumption of the company's debt and is expected to close by the end of the year, subject to shareholder and regulatory approvals.

For 2025, Integer reported $1.85 billion in total sales, an 8% increase from the prior year, and employs roughly 11,000 people. The firm is a key device contract manufacturer supplying components for cardiovascular and neuromodulation therapies.

The acquisition follows other recent large private‑equity moves in healthcare, such as AIP’s purchase of Avanos and Blackstone/TPG’s bid for Hologic.